Načítá se...
Rare anaemias, sickle-cell disease and COVID-19
For rare haematological diseases (RHD), the first question to be answered is if patients with benign red blood cell (RBC) defects like haemoglobinopathies, membranopathies and enzymopathies are more vulnerable to COVID-19 infection. Up to now, there is no yet literature on the subject, but, like in...
Uloženo v:
| Vydáno v: | Acta Biomed |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mattioli 1885
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7569637/ https://ncbi.nlm.nih.gov/pubmed/32420949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23750/abm.v91i2.9532 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|